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Abstract Early onset pancreatic cancer (EOPC) constitutes
less than 5% of all newly diagnosed cases of pancreatic
cancer (PC). Although histopathological characteristics of
EOPC have been described, no detailed reports on
precursor lesions of EOPC are available. In the present
study, we aimed to describe histopathological picture of
extratumoral parenchyma in 23 cases of EOPCs (definition
based on the threshold value of 45 years of age) with
particular emphasis on two types of precursor lesions of
PC: pancreatic intraepithelial neoplasia (PanIN) and intra-
ductal papillary mucinous neoplasms (IPMNs). The types,
grades, and densities of precursor lesions of PC were
compared in patients with EOPCs, in young patients with
neuroendocrine neoplasms (NENs), and in older (at the age
of 46 or more) patients with PC. PanINs were found in
95.6% of cases of EOPCs. PanINs-3 were found in 39.1%
of EOPC cases. Densities of all PanIN grades in EOPC
cases were larger than in young patients with NENs.
Density of PanINs-1A in EOPC cases was larger than in
older patients with PC, but densities of PanINs of other
grades were comparable. IPMN was found only in a single
patient with EOPC but in 20% of older patients with PC.
PanINs are the most prevalent precursor lesions of EOPC.
IPMNs are rarely precursor lesions of EOPC. Relatively
high density of low-grade PanINs-1 in extratumoral
parenchyma of patients with EOPC may result from
unknown multifocal genetic alterations in pancreatic tissue
in patients with EOPCs.
Keywords Pancreas.Pancreatic neoplasms.Pancreatic
ductal carcinoma.Pancreatic ducts.Intraepithelial carcinoma
Introduction
Pancreatic cancer (PC) is one of the most frequent and
most deadly abdominal cancers [1]. The mean age of
patients diagnosed with PC of ductal origin (i.e., ductal
adenocarcinoma) in the USA is 70.2 years (Surveillance,
Epidemiology, and End Results database, 1988–2003) [2].
PC is a rare diagnosis in young patients. Early onset PC
(EOPC, definition based on the threshold of 40, 45, or
50 years of age [3–9]) constitutes less than 5% of all
newly diagnosed cases of PC [4, 6, 9]. Nowadays, it is
clear that cancers in young patients need a specific
management since they often differ in molecular, epidemi-
ological, and therapeutic aspects from cancers in older
population [10, 11]. Several groups of investigators studied
the issue of EOPC [3, 4, 6–9, 12]. Inherited predisposition
and smoking are believed to be the major EOPC risk factors
[6]. Younger age of an individual patient at the PC onset may
be a hallmark of so-called familial PC [13]. However, the
mean age of patients with familial PC is less than 5 years
younger than the mean age of patients with sporadic PC [13].
That is why only a small portion of patients with familial PC
are diagnosed as EOPC [4]. Unfortunately, there are no
sensitive nor specific clinical, histopathological, genomic, or
proteomic features which could clearly distinguish EOPC
from PC in older patients [3, 9].
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DOI 10.1007/s00428-011-1056-3Pancreatic intraepithelial neoplasia (PanIN) is a well-
recognized and extensively studied precursor lesion of
PC of ductal lineage [14–23]. PanINs may present as flat,
micropapillary, or papillary noninvasive intraductal
lesions, which usually develop within small pancreatic
ducts (less than 5 mm [18–20]o rl e s st h a n1 0m mi n
diameter [15]). PanINs are divided into four categories
based on grade of dysplasia (1A, 1B, 2, and 3) [15–18, 20,
21, 23]. Low-grade PanINs (PanINs-1A, PanINs-1B,
PanINs-2) may be found in pancreata of 16–80% of
individuals without any clinically detectable pancreatic
disease. In contrast, PanINs-3 are very rarely seen in
pancreata of individuals without PC [reviewed in Refs. 16,
17]. In a proportion of cases, PanINs (particularly low-
grade ones) may be associated with obstruction of branch
pancreatic ducts. This may lead to localized atrophy of
pancreatic lobule [focal lobular atrophy (FLA)] drained by
the affected duct and subsequent focal fibrosis of the
pancreatic parenchyma [24]. Atrophy and fibrosis within
areas of FLA are frequently associated with acinar–ductal
metaplasia and formation of so-called tubular complexes.
Tubular complexes may develop within atrophic lobules
with or without associated PanIN within a draining duct.
At the advanced stage of this process, mucinous metapla-
sia within ductules of tubular complexes may develop
(mucinous tubular complexes) [25, 26]. It should be
distinguished from PanIN (i.e., mucinous change within
pre-existing duct) [27].
PanINs and FLAs are more frequent in older individuals,
and therefore, they are believed to represent an age-related
phenomenon [24, 28, 29]. However, PanIN–FLA com-
plexes are particularly frequent in pancreata of individuals
with a strong family history of PC [19, 26, 30]. This may
be very useful for screening of persons with high risk of
developing PC, since FLAs may be visualized by endoscopic
ultrasonography [19, 26, 30–34].
Up to 20% of ductal PC (both sporadic and familial) are
derived from other type of PC precursor lesions–intraductal
papillary mucinous neoplasms (IPMNs) [19].
Rare reports on histopathological characteristics of
EOPCs are available [3, 9]. In contrast, we are not aware
of any detailed reports on precursor lesions of EOPC.
Therefore, in the present study, we aimed to provide a
histopathological description of extratumoral pancreatic
parenchyma (EPP) in patients with EOPCs. We particularly
emphasized morphological types of EOPC precursor
lesions and their density in EPP.
Materials and methods
The study was performed in concordance with the Helsinki
Declaration.
Study design and selection of cases
We reviewed retrospectively all cases of pancreatic resections
received and diagnosed in our institution between January
1985 and December 2010. In all cases, available clinical data,
gross pathology reports, as well as microscopic slides, were
reexamined by two of the authors (LL and JP). Histopa-
thological diagnoses were based on the criteria published in
the U.S. Armed Forces Institute of Pathology Fascicle [35]
and the recent World Health Organization reference book
[36]. A minority (less than 10%) of cases were not available
for rereview, and these cases were excluded from the study.
The main study group (EOPC cases)
The main study group included patients with pancreatic
ductal adenocarcinoma diagnosed at the age of 45 and
younger between 1985 and 2010. These patients were
diagnosed as EOPCs. The age cut-off value we imple-
mented here (45 years) was selected based on the largest so
far study of patients with EOPC performed by Dr. Duffy
and associates at Memorial Sloan Kettering Cancer Center,
New York [4]. Patients with neoplasms of non-ductal origin
[e.g., acinar cell carcinomas, neuroendocrine neoplasms
(NENs), solid pseudopapillary neoplasms] were carefully
excluded from the main study group. Cases of invasive
carcinomas associated with mucinous cystic neoplasms
were also excluded since their pathogenesis, demographic
characteristics, and clinical presentation differ in significant
extent from those of PCs [35, 36].
Control groups
For comparative purposes, we distinguished two control
groups.
Control group 1 included cases of primary pancreatic
NENs diagnosed in patients at the age of 45 or less between
1985 and 2010. That control group was established since it
is highly probable that the prevalence of PC precursor
lesions in patients with NENs represent their “baseline”
prevalence in the general population. It was showed
previously that the prevalence of PC precursor lesions in
patients with NENs is primarily related to the patients’ age
and/or presence of chronic pancreatitis [37, 38]. Moreover,
there is no convincing evidence that NENs are related
pathogenetically to PanINs/IPMNs [35].
Control group 2 included patients with pancreatic ductal
adenocarcinoma diagnosed at the age of 46 or older in 2009
and 2010. That control group was established since we aimed
to examine whether types and density of PC precursor lesions
inpatientswithEOPCdifferfromPCprecursorlesionsinolder
patients. This could potentially indicate that PCs in younger
and older patients differ in some aspects of their pathogenesis.
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All available slides of cases of EOPCs and control groups
were examined for the presence of EPP. Since in the present
study we aimed to describe the characteristics of PC
precursor lesions, we selected a subgroups of cases of
EOPCs, NENs in young patients, and PCs in older patients
in which at least 2 cm
2 of EPP was found. In some
specimens, smaller portions of EPP were available for
review. In those cases, EPP was frequently localized in a
very close proximity to the tumor border, and it showed
usually changes compatible with mass-related atrophy and/or
inflammation.
ThemainlesionswhichEPPwassearchedforwerePanINs
and IPMNs [15, 16]. In cases when the particular precursor
lesion was less than 0.5 cm in diameter, it was classified as
PanIN. When it was larger than 0.5 cm but smaller than
1 cm, it was called “incipient IPMN.” Larger lesions were
named as IPMNs. These diagnostic categories were based on
the previous study [19]. The grade of dysplasia within
PanINs was assessed using internationally accepted criteria
[18]. In cases of IPMNs/incipient IPMNs, grade of dysplasia
(low grade, moderate grade, or high grade) as well as
histopathological variant (gastric foveolar, intestinal, pan-
creatobiliary, oncocytic) was described [35, 39]. PanINs-3
and incipient IPMNs with high-grade dysplasia were
classified as high-grade PC precursor lesions [19]. Reactive
atypical epithelium, transitional/squamous cell metaplasia, as
well as cancerization of ducts, were taken into account in
differential diagnosis of PanINs/IPMNs and carefully
excluded before establishing the PanINs/IPMNs diagnosis,
based on previously proposed criteria [17, 18]. In particular,
abrupt transition from highly dysplastic epithelium to the
“normal” epithelium, continuity of dysplastic intraductal foci
with invasive carcinoma, as well as flat rather than (micro)
papillary configuration of the lesion, were considered as
hallmarks of secondary colonization of pre-existing ducts by
invasive carcinoma rather than the presence of primary non-
invasive high-grade lesion, PanIN-3 [17, 18].
EPP was also searched for foci of FLA related to PanINs
[24]. Acinar cell atrophy, islet aggregation, tubular com-
plexes, small intralobular retention cysts, fatty change, as well
intralobular fibrosis, are frequently seen in FLAs [19, 24–26,
28, 30, 40–42]. Additionally, a subcategory of FLA
associated with mucinous tubular complexes was separately
distinguished.
EPP areas were additionally studied for other lesions of
ductal origin (squamous cell metaplasia, goblet cell
metaplasia, oncocytic metaplasia, mucinous nonneoplastic
cysts), acinar origin (acinar cell nodules), endocrine origin
(endocrine-ductular/ductuloinsular lesions, NENs), and
centroacinar/intercalated origin (squamoid cysts, centroacinar
cellhyperplasia,microscopicserouscystic,orsolidneoplasms)
[27, 35, 42, 43]. Intensity of fibrosis was described
semiquantitatively as mild, moderate, or marked. Moreover,
histopathological features suggestive of acute pancreatitis
were documented if present [44].
Data analysis and statistics
In each case, duct profiles containing PC precursor lesions
were counted. The EPP surface was measured directly on
microscopical slides with the area rounded up to nearest
0.25 cm
2. The densities of PC precursor lesions were
calculated as a number of lesions per square centimeter of
EPP (PanIN-1A density, PanIN-1B density, PanIN-2
density, PanIN-3 density, overall PanIN density, low-grade
incipient IPMN density, moderate-grade incipient IPMN
density, high-grade incipient IPMN density, overall incipient
IPMN density, overall PC precursor density, overall high-
grade PC precursor density) [19]. PanINs and IPMNs
visualized in the main pancreatic duct were documented
but not included in the above counts.
Additionally, in each case, the proportion of PanINs
associated with FLAs among all PanIN lesions (FLA to PanIN
rate) and the proportion of PanINs associated with FLAs with
mucinous tubular complexes among all PanIN lesions (rate of
mucinous tubular complexes to PanINs) were calculated.
Medians of densities of PC precursor lesions, FLA-related
rates, and patients’ age were compared between the main
study group and control groups using Mann–Whitney U tests.
Proportions were compared between study groups using
Fisher’s exact tests. The statistical relationship between
patients’ age and PanINs’ densities was assessed using the
Spearman’s rank correlation coefficient. All statistical tests
were two-tailed. Significance was set up at p≤0.05.
Results
Basic clinical and histopathological characteristics
of EOPCs and control cases
We selected only these resected cases of EOPCs, NENs in
young patients, and PCs in older patients, in which adequate
EPP area (at least 2 cm
2) could be examined. Therefore, the
study included 23 out of 26 EOPC cases, 13 out of 22 NEN
cases in young patients (the two additional enucleated
tumors not taken into account), and 41 out of 44 PCs in
older patients.
Two cases of PCs in older patients were then excluded
since they were associated with intraductal tubulopapillary
neoplasms [36]. At the moment, it is not clear whether
intraductal tubulopapillary neoplasms represent a morpho-
logical variant of IPMNs or rather separate intraductal
pancreatic lesions of separate origin and/or differentiation.
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included in the present study were presented in Table 1.A
single EOPC case was diagnosed as familial PC—the two
first-degree relatives of that patient were affected with PC.
Another EOPC patient had a family history of a single case
of PC. Another EOPC patient had a family history of
multiple cancers of different types and locations. There was
no family history of PC in young patients with NENs. Two
patients with PC older than 45 years had a first-degree
relative with PC. Another two patients with PCs at the age
above 45 years had a family history of several PC cases, but
no case was diagnosed in first-degree relatives. No family
history of three patients with PC at the age above 45 years
was available. None of the patients or their family kindred in
the main study group and in the control groups was
diagnosed with hereditary syndromes associated in an
increased risk of developing PC.
The median value of age of patients with EOPC was
6.0years higherthan themedianvalueofageof youngpatients
with NENs (Mann–Whitney U test, p=0.087, Table 1). Lack
of (statistical) significance concerning that comparison might
result from relatively small numbers of patients included, but
we believe that difference was of no “clinical” significance.
Previously reported PanIN prevalence rates in individuals in
their 30s and 40s seemed to be comparable [23, 29]. It is not
known, however, whether densities of PC precursor lesions in
individuals in their 30s and 40s are the same.
Only 1 out of 23 EOPC cases (4.4%) was derived from
IPMN. That was colloid carcinoma [45]a s s o c i a t e dw i t h
intestinal type IPMN with moderate and focally high-grade
dysplasia present within the main pancreatic duct and
additionally in a branch duct. In contrast, 8 out of 39
(20.5%) studied cases of PC in older patients were associated
with IPMNs. That difference was of no statistical (Fisher’s
exact test, p=0.136) but possibly of clinical significance.
Among older patients with PCs, two cases of colloid
carcinomas were associated with intestinal type IPMNs,
three cases of tubular carcinomas were associated with
pancreaticobiliary-type IPMNs (one with focal oncocytic
differentiation), two cases of tubular carcinomas were
associated with gastric foveolar-type IPMNs and a single
case of tubular carcinoma was associated with IPMN of
mixed differentiation. All cases were present in main
pancreatic ducts and in some proportion of branch ducts.
The detailed data on clinical–pathological characteristics of
all EOPC cases are to be described in a separate manuscript
(in preparation).
EPP in patients with EOPCs (main study group)
Among 23 studied patients, PanINs (Fig. 1a–b) were found
in 22 (95.6%) of them. PanINs-3 were found in nine
(39.1%) cases. The overall PanIN density ranged from 0.0
to 2.00 lesions cm
−2 of EPP. The PanIN-3 density ranged
from 0.0 to 0.60 lesions cm
−2 of EPP. As mentioned earlier,
a single PC developed from IPMN (Fig. 2a–b). IPMNs or
incipient IPMNs were not found in any other EOPC cases.
FLAs (Fig. 3a–f) were present in 13 cases (from one to five
lesions per case); in seven of them, they showed features of
mucinous tubular complexes. The FLA to PanIN rate ranged
Table 1 Basic clinical and histopathological characteristics of patients with EOPCs and patients in control groups 1–2
Variable Main study group: EOPCs (n=23) Control group 1: NENs
of the pancreas in
young patients (n=13)
Control group 2: Ductal pancreatic
adenocarcinomas in older patients (n=39)
Gender
(male/female)
13:10 7:6 23:16
Age (median,
interquartile
range)
42.0 (40.0–44.0)
a 36.0 (35.0–44.0)
a 60.0 (55.0–66.0)
Localization
(head/body/
tail/
more than
1 segment/not
known)
18:0:2:3:0 5:1:6:0:1 37:0:1:1:0
Tumor
characteristics
21 cases of conventional ductal
adenocarcinoma, a single case of
undifferentiated carcinoma, a single case
of invasive carcinoma associated with
IPMN (colloid carcinoma)
12 cases of neuroendocrine
tumors G1/G2, a single case of
(poorly differentiated)
neuroendocrine carcinoma
30 cases of conventional ductal
adenocarcinoma, a single case of
undifferentiated carcinoma, eight cases of
invasive carcinoma associated with IPMN
(six of tubular differentiation and two of
colloid differentiation)
EOPC Early onset pancreatic cancer; NEN neuroendocrine neoplasm; IPMN intraductal papillary mucinous neoplasm
aMedian age of patients with EOPCs versus median age of young patients with NENs, Mann–Whitney U test, p=0.087
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complexes to PanINs ranged from 0.0 to 0.33. Two patients
showed features of moderate to marked chronic obstructive
pancreatitis. Fat necrosis was seen focally in six cases.
Amyloid deposits in islets, small oligocystic serous adenoma,
PanIN-1A within the main pancreatic duct (not included in
the above counts) were present in one case each. In one
patient, there was a neuroendocrine tumor G1 coexistent with
PC. In EPP of a single case, diffuse centroacinar cell
hyperplasia (Fig. 4), but no PanINs were found. The
significance of this finding remained unknown. In several
cases, invasive carcinoma secondarily involved pre-existing
ducts (Fig. 5a–b).
EPP in young patients with NENs (control group 1)
Among the 13 NENs studied, PanINs were found in eight
cases. PanIN-1A lesions in the main pancreatic ducts were
found in two additional cases. In a single patient, ductules
with PanINs-1Awere entrapped within tumor mass (so-called
ductuloinsular neuroendocrine tumor). Incipient IPMNs and
high-gradePCprecursorlesionswereabsent.FLAsassociated
with PanINs were present in seven cases. In four of these
cases, mucinous tubular complexes were found. In one
patient, mucinous nonneoplastic cyst, amyloid islet deposi-
tions as well as islet microadenomatosis were found. In
another patient,a smallsquamoidcystwas found.Focus offat
necrosis and focal squamous cell metaplasia of branch
pancreatic duct were found in one case each. Features of
moderate chronic pancreatitis were present in two cases. A
single patient showed histopathological features of groove
(paraduodenal) pancreatitis with duodenal intramural cyst.
EPP in older patients with PC (control group 2)
PanINs were found in all 39 cases studied. PanINs-3 were
visualized in 30 (76.9%) out of 39 cases. The figures
concerning PanIN prevalence in older patients obviously
cannot be compared to the parallel values in EOPC group
since the studied EPP areas in both groups did evidently
differ. The overall PanIN density ranged from 0.21 to
Fig. 2 a–b IPMN in patient with EOPC. That was intestinal type
neoplasm within the main pancreatic duct and branch ducts which
progressed to colloid (mucinous noncystic) carcinoma (not shown)
Fig. 1 a–b PanIN in patients with EOPCs. a PanIN-1B. b PanIN-3
(micropapillary pattern)
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−2 of EPP. The PanIN-3 density ranged from
0.0 to 0.44 lesions cm
−2 of EPP. As mentioned earlier, eight
cases were associated with IPMNs. Incipient IPMNs were
found in branch ducts of all of these eight patients, but they
presented different grades of dysplasia, morphological
types, and extent of EPP involvement. A single incipient
IPMN of low-grade dysplasia and gastric foveolar differ-
entiation was found in the EPP area peripheral to the
Fig. 3 a–f FLA related to low-grade PanIN in patients with EOPCs.
Intralobular fibrosis, acinar dropout, “naked” islets, ductules with
mucinous metaplasia (mucinous tubular complexes). In some tubular
complexes, residual acinar cells intermixed with mucin-rich metaplas-
tic cells (d, e). Mucinous tubular complexes in close proximity to
residual islets (f)
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to the PanIN-3. The FLA to PanIN rate in older patients
with PCs ranged from 0.0 to 0.79, whereas the rate of
mucinous tubular complexes to PanINs ranged from 0.0 to
0.64. Twelve patients showed features of moderate to
marked chronic obstructive pancreatitis. Fat necrosis was
seen focally in seven cases. Pseudocysts were found in two
cases. Squamous cell metaplasia of pancreatic dusts was
seen in 11 cases; in two of them, it was extensively
distributed in EPP. Neuroendocrine microadenomas were
noticed in four patients (in one of them, two lesions were
visualized). Squamoid cyst was found in a single patient. In
another single patient, well-developed epithelioid granulo-
mas with Langhans cells but without necrosis were found in
EPP and in several peripancreatic lymph nodes. PanINs-
1A, PanINs-1B, PanINs-2, and PanINs-3 in main pancreatic
duct were found in 1, 3, 1, and 1 patient, respectively.
Comparison of densities of PC precursor lesions in patients
with EOPCs and in young patients with NENs
Densities of PanINs of all grades were significantly larger
in EPP of patients with EOPCs as compared to EPP of
young patients with NENs (Table 2). However, there were
no differences concerning the rate of FLAs to PanINs and
the rate of mucinous tubular complexes to PanINs between
those groups of patients.
Comparison of densities of PC precursor lesions in patients
with EOPCs and in older patients with PCs
Densities of PanINs-1B, PanINs-2, and PanINs-3 in EPP of
patients with EOPCs and older patients with PCs were
comparable (Table 2). In contrast, density of PanINs-1A
was twofold larger in cases of EOPC than in older PC cases.
This fact contributed to statistically significant difference of
overall PanIN density between the main study group and
control group 2. In contrast, rate of FLAs to PanINs and the
rate of mucinous tubular complexes to PanINs were higher
in older patients with PCs in comparison with patients with
EOPCs. Since more cases of PC in older patients with PCs
than cases of EOPC were related to IPMNs, it was not
surprising that the densities of incipient IPMNs (except those
of moderate grade) were higher in the former group. Overall
density of PC precursor lesions was larger patients with
EOPCs, but overall density of high-grade PC precursor
lesions was higher in older patients with PCs.
Correlation between patients’ age and PanINs’ densities
We did not find significant correlations between patients’ age
and overall PanIN density in EOPC patients and in young
Fig. 5 a–b Secondary cancerization of pre-existing ducts by invasive
carcinoma. Conventional ductal adenocarcinoma with abundant
intracellular mucin involving normal branch duct (a) and undifferen-
tiated carcinoma (b) involving branch duct with PanIN-1A (all figures
in hematoxylin and eosin)
Fig. 4 Centroacinar cell hyperplasia
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p=0.992 and p=0.725, respectively). In contrast, overall
PanIN density was rather weakly but significantly positively
correlated with age of older patients with PC (r=0.330,
p=0.040). Similar levels of correlation were found between
age of older patients with PCs and their overall PC precursor
density and overall high-grade PC precursor density, but not
incipient IPMN density (specific data not shown).
Table 2 PC precursor lesions in extratumoral parenchyma of patients with EOPCs and patients in control groups 1–2
Variable Main study group:
EOPCs (n=23)
Control group 1:
NENs of the pancreas in
young patients (n=13)
Control group 2:
ductal pancreatic
adenocarcinomas in
older patients (n=39)
Studied area of EPP (cm
2, median, IQR) 6.0 (4.0–7.0) 6.0 (4.0–9.5) 19.0 (15.5–33.0)
Prevalence of PanINs-1A 22/23 7/13 39/39
Density of PanINs-1A
(no. of lesions cm
−2, median, IQR)
0.40 (0.24–0.77) 0.11 (0.0–0.21), p=0.0001
a 0.19 (0.12–0.27), p=0.0002
b
Prevalence of PanINs-1B 21/23 7/13 39/39
Density of PanINs-1B
(no. of lesions cm
−2, median, IQR)
0.34 (0.17–0.50) 0.07 (0.0–0.21), p=0.006
a 0.26 (0.16–0.42), p=0.536
b
Prevalence of PanINs-2 15/23 0/13 37/39
Density of PanINs-2
(no. of lesions cm
−2, median, IQR)
0.17 (0.0–0.25) 0.0 (0.0–0.0), p=0.0003
a 0.12 (0.06–0.16), p=0.683
b
Prevalence of PanINs-3 9/23 0/13 30/39
Density of PanINs-3
(no. of lesions cm
−2, median, IQR)
0.0 (0.0–0.17) 0.0 (0.0–0.0), p=0.012
a 0.07 (0.02–0.12), p=0.069
b
Overall prevalence of PanINs 22/23 8/13 39/39
Overall density of PanINs
(no. of lesions cm
−2, median, IQR)
1.20 (0.75–1.33) 0.17 (0.0–0.42), p=0.0001
a 0.71 (0.47–1.04), p=0.003
b
Prevalence of FLA 13/23 7/13 38/39
Rate of FLA to PanINs
(median, IQR)
0.17 (0.0–0.33) 0.32 (0.21–1.0), p=0.077
a 0.29 (0.19–0.52), p=0.018
b
Prevalence of mucinous tubular complexes 7/23 4/13 28/39
Rate of mucinous tubular complexes
to PanINs (median, IQR)
0.0 (0.0–0.13) 0.1 (0.0–0.58), p=0.135
a 0.17 (0.0–0.28), p=0.002
b
Prevalence of low-grade incipient IPMNs 0/23 0/13 7/39
Density of low-grade incipient IPMNs
(no. of lesions cm
−2, median, IQR)
0.0 (0.0–0.0) 0.0 (0.0–0.0), NA 0.0 (0.0–0.0), p=0.034
b
Prevalence of moderate-grade incipient IPMNs 1/23 0/13 7/39
Density of moderate-grade incipient
IPMNs (no. of lesions cm
−2, median, IQR)
0.0 (0.0–0.0) 0.0 (0.0–0.0), p=0.488 0.0 (0.0–0.0), p=0.154
b
Prevalence of high-grade incipient IPMNs 0/23 0/13 8/39
Density of high-grade incipient IPMNs
(no. of lesions cm
−2, median, IQR)
0.0 (0.0–0.0) 0.0 (0.0–0.0), NA 0.0 (0.0–0.0), p=0.022
b
Overall prevalence of incipient IPMNs 1/23 0/13 9/39
Overall density of incipient IPMNs
(no. of lesions cm
−2, median, IQR)
0.0 (0.0–0.0) 0.0 (0.0–0.0), p=0.488 0.0 (0.0–0.0), p=0.059
b
Overall prevalence of precursor lesions of PC 22/23 8/13 39/39
Overall density of precursor lesions of PC
(no. of lesions cm
−2, median, IQR)
1.20 (0.87–1.33) 0.17 (0.0–0.42), p=0.0001
a 0.75 (0.48–1.08), p=0.008
b
Overall prevalence of high-grade precursor lesions of PC 9/23 0/13 32/39
Overall density of high-grade precursor lesions of PC
(no. of lesions cm
−2, median, IQR)
0.0 (0.0–0.17) 0.0 (0.0–0.0), p=0.012
a 0.09 (0.05–0.18), p=0.024
b
EOPC Early onset pancreatic cancer, NEN neuroendocrine neoplasm, EPP extratumoral pancreatic parenchyma, IQR interquartile range, PanIN
pancreatic intraepithelial neoplasia, FLA focal lobular atrophy, IPMN intraductal papillary mucinous neoplasm, NA not available (cannot be calculated),
PC pancreatic cancer
aMedian values of studied variables in patients with EOPCs versus median values in young patients with NENs, Mann–Whitney U tests,
statistically significant results are in bold
bMedian values of studied variables in patients with EOPCs versus median values in older patients with ductal pancreatic adenocarcinomas,
Mann–Whitney U tests, statistically significant results are in bold
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Pathogenesis and histopathology of EOPC
Due to its rarity, there is relatively small amount of data
concerning epidemiology, symptomatology, optimal
treatments options, as well as long-term prognosis in
EOPC [3, 4, 6, 9]. Bergmann et al. [3]a n dL ü t t g e se ta l .
[9] presented data on histopathology and molecular
characteristics of EOPC. The pathogenesis of EOPC is
poorly understood. Some PC cases including EOPC ones
may be associated with individual genetic predisposition
[46]. Noteworthy, the percentage of EOPC patients with
positive family history of PC (10.3%) [4] is similar to the
percentage in overall population of patients with PC
(8.5%) [47]. Our data were in concordance with those
observations. Interestingly, none of 136 EOPC cases in the
study of Duffy et al. [4] and none of EOPC cases in the
present study were associated with inherited syndromes
associated with elevated risk of developing PC. Only a
single patient with EOPC in the present study was
diagnosed with familial PC. The issue of familial PC was
extensively reviewed previously [33, 46, 48].
PanINs prevalence and densities
Several groups of investigators studied the prevalence of
PC precursor lesions in patients without clinically
detectable pancreatic diseases and/or patients with
different types of tumors of non-ductal origin [21, 23,
29, 37, 38, 49–51].
PanINs are very frequent in adult pancreata (up to 80% of
cases studied), but the prevalence rates of PanIN of different
grades of dysplasia differ significantly [16, 21, 23, 29, 49,
50]. PanINs-1A lesions are more prevalent (19–68.2% [21,
49–51]) as compared to PanINs-1B (12–20% [23, 49–51])
and PanINs-2 lesions (0–13.6% [49–51]). PanINs-3 lesions
are very rare [37] or nonexistent in patients without PC [21,
23, 49–51]. In our opinion, the differences between studies
concerning PanIN prevalence rates in patients without PC
may be caused by a number of methodological causes, e.g.,
different criteria of inclusion of patients across the studies,
extensiveness of EPP sampling, or technique of statistical
reporting.
Concerning the issue of PanIN prevalence in individuals
without detectable pancreatic diseases, PanINs are more
prevalent in older persons in comparison to younger ones
(reviewed in Refs. [16, 17]). However, it is not definitely
clear if the grade of PanINs found in asymptomatic
individuals increases with their age, since results of
different studies are discrepant [21, 29, 37, 49, 50]. Even
if such a correlation exists, it is rather weak [37]. There is
no significant difference between genders in the prevalence
of PanINs [21, 23, 29, 50]. The PanIN prevalence is not
associated with history of tobacco smoking [19, 23]o r
alcohol abuse [23]. Is it not definitely clear whether PanIN
prevalence is higher in the pancreatic head in comparison to
other segments [16], since results of studies on that issue
were inconsistent [21, 23, 26, 29].
In the present study, we assumed that prevalence of
PanINs in patients with NENs may be an indicator of their
prevalence in individuals without pancreatic diseases.
That was acknowledged by Stelow et al. [37]a n d ,v e r y
recently, by Recavarren et al. [38]. However, the average
age of patients with NENs included in those reports was
above 45 years; that is, they were in significant proportion
older than patients with NENs included in the present
study. This may explain why we did not see PanINs-2 and
PanINs-3 in patients with NENs despite they were seen
(albeit rarely) in patients with NENs described in those
reports [37, 38].
It is clear that PanIN-2 and PanIN-3 lesions are not
supposed to be found in young patients without PCs (vide
control group 1 in the present study), but they exist in
patients with PCs (both younger and older ones). The
PanINs-3 prevalence in patients with EOPCs in the present
study was 39.1%. It was much lower than the PanINs-3
prevalence in older patients (76.9%, high-grade incipient
IPMNs not included). That was obviously caused by
differences in the studied EPP areas between those groups;
therefore, it was of no significance.
Recently, it was proposed that not only prevalence of
PanINs of different grades but also their density in EPP
may be of clinical significance [19]. The issue of densities
of PC precursor lesions was also raised in earlier studies
[21, 23]. It is not known whether PanIN densities differ in
young and older patients with or without PCs and whether
PanIN density may change in a particular individual during
his/her lifetime. Lüttges et al. [21] did not find any
differences in numbers of intraductal lesions (compatible
with present-day PanINs and squamous cell metaplasias) in
systematically sampled pancreata of autopsied patients aged
6–92 who died of nonpancreatic diseases. This may
indicate that PanIN density is relatively constant during
lifetime in individuals who did not develop PC.
There is more data on PanIN density in patients with
PCs. Shi et al. [19] showed that EPP in patients with
familial PCs contained 2.75 times more PanINs than EPP in
patients with sporadic PCs (PanIN densities of 1.51 and
0.55 lesions cm
−2 of EPP, respectively). The densities of all
grades of PanINs were higher in familial PCs than in
sporadic cases. Incipient IPMNs were detected in EPP in
one third of familial PC cases, and their density was 11.8
times higher in familial PC cases than in sporadic ones [19].
The densities on PanINs in older patients with PCs reported
in the present study (control group 2) were comparable, but
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sporadic PC cases.
The median overall PanIN density in EOPC cases
examined in the present study (1.20 lesions cm
−2)w a s
significantly higher than PanIN density in older patients
with PCs (0.75 lesions cm
−2) and slightly lower than
previously mentioned PanIN density in familial PC cases
in the study of Shi et al. [19]. This finding was quite
intriguing since only one patient with EOPC in the
present study was diagnosed with familial PC. However,
it should be noticed that significant differences in PanIN
densities between particular patients with PCs may exist.
S h ie ta l .[ 19] showed that overall PanIN densities in
patients with familial PCs and sporadic PCs may range
from 0 to 3.8 and from 0 to 2.01 lesions cm
−2 of EPP,
respectively. We also noticed differences in overall PanIN
density ranging from 0 up to 2 lesions cm
−2 in both
young and older patients with PCs. However, in any of
the studied patients the overall PanIN density was not as
high as 3.8 lesions cm
−2 of EPP.
We did not observe statistically significant differences
concerning densities of PanINs-1B, PanINs-2, and PanINs-3
between patients with EOPCs and older patients with PCs.
In contrast, the PanIN-1A density in patients with EOPCs
was significantly higher than in older patients with PCs.
We are not aware on any other studies on the relationship
between PanIN-1A density and age of patients with PCs.
It is possible that some PanIN-1A lesions may progress to
PanINs-1B, and therefore, their density in older patients
with PCs may decline. However, as mentioned earlier, we
did not see any increase of PanIN-1B density in older
patients with PCs as compared to younger ones. PanIN-1B
density in older patients with PCs was even paradoxically
l o w e rt h a ni np a t i e n t sw i t hE O P C s ,b u tt h a td i f f e r e n c ew a s
not statistically significant. Lüttges et al. [21] showed that
prevalence of mucinous cell hypertrophy (present-day
PanINs-1A) but not ductal papillary hyperplasia (present-day
PanINs-1B and PanINs-2) increased with age of individuals
without PCs.
In the present study, we also showed that densities of
PanIN of all grades (including low-grade ones) were
significantly higher in patients with EOPCs than in young
patients with NENs.
Higher PanINs-1A density in patients with EOPCs as
compared to young patients with NENs and older patients
with PCs may indicate that in at least some EOPC patients,
there is a tendency to develop multifocal low-grade PanINs.
Although a great majority of these low-grade lesions did
not progress to high-grade ones and invasive carcinomas
(we did not observe any multifocal cancers in any of the
studied cases), their relatively high density might reflect an
alteration of some “gatekeeper” genes similarly as it was
postulated by Shi et al. [19] in familial PC.
IPMNs prevalence
In the present study, only one EOPC (4.3%) was associated
with IPMN. In contrast, as many as 20% of cases of PCs in
older patients were associated with IPMNs. That percentage
was higher than the prevalence of invasive carcinomas
associated with IPMNs among resected ductal PCs reported
inthelargeseriespresentedbyPoultsidesetal.[52] (132/1260,
10.5%). At present, IPMNs do not seem to be particularly
frequent PC precursor lesion among patients with EOPCs, but
further studies related to this issue are needed.
Focal lobular atrophy
Detlefsen et al. [24] and Kloppel et al. [28] showed that
FLAs are frequent feature of pancreata of persons without
clinically detectable pancreatic disorders. Interestingly, it
may be often but not always associated with intraductal
lesions mainly PanIN-1B. That seemed to be age-related
phenomenon [24, 28]. Adenomatous hyperplasia of pan-
creatic ducts [21, 29], which probably equals to mucinous
tubular complexes [25], was reported in 40% of “normal”
pancreata and 26.9% of cases of normal pancreata with
“ductal hyperplasia” [21, 29]. Changes compatible with
FLA may be found in approximately one third of normal
pancreata with ductal hyperplasia [29]. Meckler et al. [53]
described in detail parenchymal changes in members of the
family with many cases of PCs. They found FLAs with
cystic transformation and “mucinous metaplasia” of the
intralobular ductules, PanINs of all grades, interstitial
endocrine cell hyperplasia, numerous endocrine cells within
ductal epithelial lining, and nuclear atypia in some
endocrine cells and rarely mild inflammatory infiltrate,
squamous cell metaplasia [53]. Later Brune at al. [26]
showed that similar lesions but of high density may be
found in patients without clinically detectable PC but with
strong family history of PC. These patients presented
multiple foci of PanINs of all grades as well as IPMNs with
low-grade dysplasia [26]. FLAs were related to almost all
PanIN lesions including PanINs-1A [26]. Brune et al. [26]
also documented less frequent FLAs associated with PanINs
(including PanIN-1A) in patients without PCs. Moreover,
PanIN-1B lesions may undergo “cystic transformation” to
gastric foveolar IPMN [16]. FLA related to PC precursor
lesions may be actually focal or multifocal response to
pancreatic duct obstruction, since it closely resembles
obstructive chronic pancreatitis [28]. It is possible to detect
lobular fibrosis which is caused by obstruction of lobular
duct by intraductal lesion using endoscopic ultrasonography
[26, 30–34, 54]. In rare cases, multicentric PanINs with
associated lobular atrophy and fibrosis involving the entire
pancreas may develop in patients with negative family
history of PC [55]. PanINs and IPMNs lesions with or
448 Virchows Arch (2011) 458:439–451without associated FLAs were also documented in patients
from families with familial PCs submitted to prospective
screening programs [30, 32, 33].
Related issue is the rate of FLAs to PanINs in patients with
and without PCs. Detlefsen et al. [24] found FLA in one of
four autopsied patients with PanIN-1B lesions under the age
of 60 years without clinical or grossly detectable pancreatic
disease. In patients at the age of 60 or older, PanIN-1B–FLA
complexes were found in 25/31 (80.6%) of cases [24]. Shi et
al. [19] showed that the prevalence rates of FLAs in both
familial and sporadic PC cases is related to the frequency of
PC precursor lesions and they were 86% and 53%,
respectively. The fact that the prevalence of PanIN-1B–FLA
complexes in autopsied persons without evident pancreatic
diseases at the age of 60 or older in the study of Detlefsen et
al. [24] was higher than the prevalence of FLA in patients
with sporadic PCs in the study of Shi et al. [19]i sq u i t e
intriguing. It indicates that some not yet known factors may
influence results of studies on FLAs. The parenchymal
changes compatible with FLA diagnosis may be of different
stage [26] and extent and the FLA prevalence may be related
to the “threshold” of features, which are identified as sufficient
for the diagnosis of FLA. The FLA prevalence may be also
related to extensiveness of EPP sampling. We found FLAs in
as many as 38/39 (97.4%) of older patients with PCs.
However, EPP was very extensively sampled, and we saw a
correlation between EPP area and the number of FLAs in EPP
of those patients (specific data not shown). FLA changes are
also similar in pathogenesis and histopathology to obstructive
pancreatitis [24, 28]. Such changes are more prevalent in the
portion of pancreas distal to the tumor, which obstruct the
duct. In the present study, we examined a low number of
tumors (PCs and NENs) localized in the body or tail of the
pancreas and therefore were not able to assess whether the
localization of tumor influenced the prevalence of FLA.
In the present study, the rate of FLA to PanINs and the rate
of FLA with mucinous tubular complexes to PanINs in
patients with EOPCs did not differ from those in young
patients with NENs, but they were significantly lower than in
older patients with PCs. This may indicate that the increase of
these rates represent an age-related phenomenon in patients
withPCs,similarlytopatientswithout PCs[24]. We observed
statistically significant correlations between the rate of FLA
to PanINs (r=0.368, p=0.003) and the rate of FLA with
mucinous tubular complexes to PanINs (r=0.509,p=0.0001)
versus age in all studied patients with PCs.
Other lesions in pancreatic parenchyma of EOPC
and control cases
Lesions other than PanINs/IPMNs/FLAs found in EPP of
cases studied in the present study did not seem to be related
to the development of PC. Their prevalence rates were too
low to be reliably compared between the study groups.
Interestingly, we did not observe any cases of microscopic
hyperplasia of endocrine component or exocrine-to-endocrine
metaplasia, which may be related to the obstruction of
pancreatic ducts and may represent a field effect in both
ductal and endocrine component in patients at high risk of PC
developmentorpatientswithfamilialPCs[31, 41, 53]. In one
single patient with EOPC, a separate NEN was found, but
the significance of that finding was unclear. The EPP in that
patient did not show any features of endocrine cell
hyperplasia or microadenomatosis.
Study limitations
The limitation of the study resulted from the fact that not
all EPP present in the specimen was submitted to
histopathological examination. Majority of EOPCs were
sampled and diagnosed before we introduced protocols
of very extensive sampling of pancreatectomy specimens
[56]. This may explain why PanIN-3 density was (albeit not
significantly) lower in patients with EOPCs in comparison
with older patients with PCs. In some cases of EOPCs, the
studied EPP area might be not large enough to detect
PanINs-3.
Another limitation may be related to the presence of
features of chronic pancreatitis in the studied cases since it
may influence the prevalence of PC precursor lesions [23].
Moderate or marked features of chronic pancreatitis were
present in a small proportion of patients with EOPCs and
young patients with NENs but in 30% of older patients
with PCs.
Surgical resection is possible only in a minority of
patients with PCs. Since all EOPC cases described in the
present study were resected, we cannot exclude that very
aggressive cases of EOPCs (which are less likely to be
resectable) show different types or extent of histopatholog-
ical alterations in EPP.
Conclusion
PanINs is the most prevalent precursor lesion of EOPCs.
PanINs of all grades are frequent but not the universal
finding in EPP in patients with EOPCs. The density of all
grades of PanINs in EPP is significantly higher in patients
with EOPCs than in young patients with NENs. Density of
PanINs-1A is higher in patients with EOPCs than in older
patients with PCs, but densities of PanINs of other grades
are comparable. Some of PanINs are related to FLAs with
or without formation of mucinous tubular complexes.
EOPCs less frequently than PCs in older patients are
derived from IPMNs. Relatively high density of low-grade
PanINs in EPP of patients with EOPCs as compared to
Virchows Arch (2011) 458:439–451 449young patients with NENs and older patients with PCs may
result from unknown multifocal genetic alterations in
pancreatic tissue of EOPC patients.
Conflicts of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer
statistics, 2009. CA: A Cancer Journal for Clinicians 59:225–249
2. Wisnoski NC, Townsend CM Jr, Nealon WH, Freeman JL, Riall
TS (2008) 672 patients with acinar cell carcinoma of the pancreas:
a population-based comparison to pancreatic adenocarcinoma.
Surgery 144:141–148
3. Bergmann F, Aulmann S, Wente MN, Penzel R, Esposito I, Kleeff
J, Friess H, Schirmacher P (2006) Molecular characterization of
pancreatic ductal adenocarcinoma in patients under 40. J Clin
Pathol 59:580–584
4. Duffy A, Capanu M, Allen P, Kurtz R, Olson SH, Ludwig E,
Klimstra DS, O’Reilly EM (2009) Pancreatic adenocarcinoma in a
young patient population–12-year experience at Memorial Sloan
Kettering Cancer Center. J Surg Oncol 100:8–12
5. Baxter NN, Whitson BA, Tuttle TM (2007) Trends in the
treatment and outcome of pancreatic cancer in the United States.
Ann Surg Oncol 14:1320–1326
6. Raimondi S, Maisonneuve P, Lohr JM, Lowenfels AB (2007)
Early onset pancreatic cancer: evidence of a major role of
smoking and genetic factors. Canc Epidemiol Biomarkers Prev
16:1894–1897
7. Brune KA, Lau B, Palmisano E, Canto M, Goggins MG, Hruban
RH, Klein AP (2010) Importance of age of onset in pancreatic
cancer kindreds. J Natl Cancer Inst 102:119–126
8. Soliman AS, El-Ghawalby N, Ezzat F, Bondy ML, Soultan A,
Abdel-Wahab M, Fathy O, Ebidi G, Bassiouni N, El-Ghawalbi A,
Levin B, Abbruzzese JL (2002) Unusually high rate of young-
onset pancreatic cancer in the East Nile Delta region of Egypt. Int
J Gastrointest Cancer 32:143–151
9. Lüttges J, Stigge C, Pacena M, Klöppel G (2004) Rare ductal
adenocarcinoma of the pancreas in patients younger than age
40 years. Cancer 100:173–182
10. Bleyer A (2007) Young adult oncology: the patients and their
survival challenges. CA: A Cancer Journal for Clinicians 57:242–
255
11. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson
B (2008) Biology and clinical trials subgroups of the US National
Cancer Institute progress review group in adolescent and young
adult oncology. The distinctive biology of cancer in adolescents
and young adults. Nat Rev Canc 8:288–298
12. Zogopoulos G, Rothenmund H, Eppel A, Ash C, Akbari MR,
Hedley D, Narod SA, Gallinger S (2007) The P239S palladin
variant does not account for a significant fraction of hereditary or
early onset pancreas cancer. Hum Genet 121:635–637
13. James TA, Sheldon DG, Rajput A, Kuvshinoff BW, Javle MM,
Nava HR, Smith JL, Gibbs JF (2004) Risk factors associated with
earlier age of onset in familial pancreatic carcinoma. Cancer
101:2722–2726
14. Hruban RH, Fukushima N (2007) Pancreatic adenocarcinoma:
update on the surgical pathology of carcinomas of ductal origin
and PanINs. Mod Pathol 20:S61–S70
15. Singh M, Maitra A (2007) Precursor lesions of pancreatic cancer:
molecular pathologyand clinical implications. Pancreatology7:9–19
16. Sipos B, Frank S, Gress T, Hahn S, Kloppel G (2009) Pancreatic
intraepithelial neoplasia revisited and updated. Pancreatology
9:45–54
17. Andea AA, Basturk O, Adsay NV (2005) Pancreatic intra-epithelial
neoplasia: current clinicopathological and molecular considerations.
Curr Diagn Pathol 11:80–94
18. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra
A, Biankin AV, Biankin SA, Compton CC, Fukushima N, Furukawa
T, GogginsM,Kato Y,Kloppel G,LongneckerDS, Luttges J,Maitra
A, Offerhaus GJA, Shimizu M, Yonezawa S (2004) An illustrated
consensus on the classification of pancreatic intraepithelial neoplasia
and intraductal papillary mucinous neoplasms. Am J Surg Pathol
28:977–987
19. Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, Schulick
R, Palmisano E, Hruban RH (2009) Increased prevalence of
precursor lesions in familial pancreatic cancer patients. Clin
Cancer Res 15:7737–7743
20. Ottenhof NA, Milne AN, Morsink FH, Drillenburg P, Ten Kate
FJ, Maitra A, Offerhaus GJ (2009) Pancreatic intraepithelial
neoplasia and pancreatic tumorigenesis: of mice and men. Arch
Pathol Lab Med 133:375–381
21. Lüttges J, Reinecke-Lüthge A, Möllmann B, Menke MA,
Clemens A, Klimpfinger M, Sipos B, Klöppel G (1999) Duct
changes and K-ras mutations in the disease-free pancreas: analysis
of type, age relation and spatial distribution. Virchows Arch
435:461–468
22. Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA,
Goggins M, Hruban RH, Eshleman JR (2009) KRAS2 mutations
in human pancreatic acinar–ductal metaplastic lesions are limited
to those with PanIN: implications for the human pancreatic cancer
cell of origin. Mol Cancer Res 7:230–236
23. Andea A, Sarkar F, Adsay VN (2003) Clinicopathological
correlates of pancreatic intraepithelial neoplasia: a comparative
analysis of 82 cases with and 152 cases without pancreatic ductal
adenocarcinoma. Mod Pathol 16:996–1006
24. Detlefsen S, Sipos B, Feyerabend B, Kloppel G (2005) Pancreatic
fibrosis associated with age and ductal papillary hyperplasia.
Virchows Arch 447:800–805
25. Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher
P (2007) Hypothetical progression model of pancreatic cancer
with origin in the centroacinar–acinar compartment. Pancreas
35:212–217
26. Brune K, Abe T, Canto M, O’Malley L, Klein AP, Maitra A,
Volkan Adsay N, Fishman EK, Cameron JL, Yeo CJ, Kern SE,
Goggins M, Hruban RH (2006) Multifocal neoplastic precursor
lesions associated with lobular atrophy of the pancreas in patients
having a strong family history of pancreatic cancer. Am J Surg
Pathol 30:1067–1076
27. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin
AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS,
Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A,
Offerhaus GJ, Pérez-Gallego L, Redston M, Tuveson DA (2006)
Pathology of genetically engineered mouse models of pancreatic
exocrine cancer: consensus report and recommendations. Cancer
Res 66:95–106
28. Kloppel G, Detlefsen S, Feyerabend B (2004) Fibrosis of the
pancreas: the initial tissue damage and the resulting pattern.
Virchow Arch 445:1–8
29. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S,
Hasegawa K, Takeuchi M (1979) Relation of pancreatic duct
hyperplasia to carcinoma. Cancer 43:1418–1428
450 Virchows Arch (2011) 458:439–45130. Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina
M, Slater EP, Heverhagen JT, Gress TM, Rothmund M,
Bartsch DK (2009) Five years of prospective screening of
high-risk individuals from families with familial pancreatic
cancer. Gut 58:1410–1418
31. Steinberg WM, Barkin JS, Bradley EL III, DiMagno E, Layer P,
Canto MI, Levy MJ (2009) Should patients with a strong family
history of pancreatic cancer be screened on a periodic basis for
cancer of the pancreas? Pancreas 38:e137–e150
32. Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van
Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ
(2009) The yield of first-time endoscopic ultrasonography in
screening individuals at a high risk of developing pancreatic
cancer. Am J Gastroenterol 104:2175–2181
33. Larghi A, Verna EC, Lecca PG, Costamagna G (2009) Screening
for pancreatic cancer in high-risk individuals: a call for endo-
scopic ultrasound. Clin Cancer Res 15:1907–1914
34. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM,
Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S,
Richman J, Jagannath S, Kantsevoy SV, Kalloo AN (2006)
Screening for early pancreatic neoplasia in high-risk individuals:
a prospective controlled study. Clin Gastroenterol Hepatol 4:766–
781
35. Hruban RH, Pitman MB, Klimstra DS (2007) AFIP atlas of tumor
pathology. Fourth series. Fascicle 6. Tumors of the pancreas.
American Registry of Pathology–AFIP, Washington
36. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) (2010) WHO
classification of tumours of the digestive system. International
Agency for Research on Cancer, Lyon
37. Stelow EB, Adams RB, Moskaluk CA (2006) The prevalence
of pancreatic intraepithelial neoplasia in pancreata with
uncommon types of primary neoplasms. Am J Surg Pathol
30:36–41
38. Recavarren C, Labow DM, Liang J, Zhang L, Wong M, Zhu H,
Wang J, Francis F, Xu R (2011) Histologic characteristics of
pancreatic intraepithelial neoplasia associated with different
pancreatic lesions. Human Pathol 42:18–24
39. Furukawa T, Kloppel G, Adsay NV, Albores-Saavedra J,
Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS,
Longnecker DS, Lüttges J, Offerhaus GJ, Shimizu M,
Sunamura M, Suriawinata A, Takaori K, Yonezawa S (2005)
Classification of types of intraductal papillary-mucinous
neoplasm of the pancreas: a consensus study. Virchows Arch
447:794–799
40. Kloppel G (2004) Chronic pancreatitis of alcoholic and nonalcoholic
origin. Semin Diagn Pathol 21:227–236
41. Lardon J, Bouwens L (2005) Metaplasia in the pancreas.
Differentiation 73:278–286
42. Oertel JE (1989) The pancreas. Nonneoplastic alterations. Am J
Surg Pathol 13(Suppl 1):50–65
43. Othman M, Basturk O, Groisman G, Krasinskas A, Adsay NV
(2007) Squamoid cyst of pancreatic ducts: a distinct type of cystic
lesion in the pancreas. Am J Surg Pathol 31:291–297
44. Kloppel G (2004) Acute pancreatitis. Semin Diagn Pathol
21:221–226
45. Liszka L, Pająk J, Zielińska-PająkE ,G o łka D (2008) Colloid
carcinoma of the pancreas: review of selected pathological and
clinical aspects. Pathology 40:655–663
46. Jorgensen MT, Mortensen MB, Gerdes AM, De Muckadell OB
(2008)Familialpancreaticcancer.ScandJGastroenterol43:387–397
47. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN,
Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D
(2007) Risk factors for pancreatic cancer: case–control study. Am
J Gastroenterol 102:2696–2707
48. Shi C, Hruban RH, Klein AP (2009) Familial pancreatic cancer.
Arch Pathol Lab Med 133:365–374
49. Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, Sohn T,
Cameron JL, Yeo CJ, Hruban RH, Goggins M (2003) p16
inactivation in pancreatic intraepithelial neoplasias (PanINs) arising
inpatientswithchronicpancreatitis.AmJSurgPathol27:1495–1501
50. Ito R, Kondo F, Yamaguchi T, Kato K, Sakai Y, Saisho H,
Yamazaki K (2008) Pancreatic intraepithelial neoplasms in the
normal appearing pancreas: on their relationship with age.
Hepatogastroenterology 55:1103–1106
51. Cubilla AL, Fitzgerald PJ (1976) Morphological lesions associated
with human primary invasive nonendocrine pancreas cancer. Cancer
Res 36:2690–2698
52. Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM,
Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA, Schulick RD,
Wolfgang CL (2010) Histopathologic basis for the favorable
survival after resection of intraductal papillary mucinous
neoplasm-associated invasive adenocarcinoma of the pancreas.
Ann Surg 251:470–476
53. Meckler KA, Brentnall TA, Haggitt RC, Crispin D, Byrd DR,
Kimmey MB, Bronner MP (2001) Familial fibrocystic pancreatic
atrophy with endocrine cell hyperplasia and pancreatic carcinoma.
Am J Surg Pathol 25:1047–1053
54. Takaori K, MatsusueS, FujikawaT,Kobashi Y,ItoT, MatsuoY,Oishi
H, Takeda H (1998) Carcinoma in situ of the pancreas associated with
localized fibrosis: a clue to early detection of neoplastic lesions arising
from pancreatic ducts. Pancreas 17:102–105
55. Aimoto T, Uchida E, Nakamura Y, Matsushita A, Katsuno A, Chou K,
Kawamoto M, Naito Z, Tajiri T (2008) Multicentric pancreatic
intraepithelial neoplasias (PanINs) presenting with the clinical features
of chronic pancreatitis. J Hepatobiliary Pancreat Surg 15:549–553
56. Liszka L, Pajak J, Zielinska-Pajak E, Golka D, Mrowiec S, Lampe
P (2010) Different approaches to assessment of lymph nodes and
surgical margin status in patients with ductal adenocarcinoma of
the pancreas treated with pancreaticoduodenectomy. Pathology
42:138–146
Virchows Arch (2011) 458:439–451 451